Oncology Pharma Inc. (ONPH)

OTCMKTS · Delayed Price · Currency is USD
0.0103
0.00 (0.00%)
At close: Mar 5, 2026
10,200%
Market Cap 398.23K
Revenue (ttm) 10.21K
Net Income (ttm) 186.04K
Shares Out 38.66M
EPS (ttm) n/a
PE Ratio 2.14
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 6,332
Average Volume 2,593
Open 0.0055
Previous Close 0.0103
Day's Range 0.0055 - 0.0103
52-Week Range n/a
Beta 0.81
RSI 68.17
Earnings Date n/a

About Oncology Pharma

Oncology Pharma Inc., an oncology company, develops, manufactures, and commercializes therapeutics. The company has a collaboration and licensing agreement with Kalos Therapeutics Inc. for exploring treatment opportunities of the COVID-19 virus. The company was formerly known as SourcingLink.net Inc. and changed its name to Oncology Pharma Inc. in June 2019. Oncology Pharma Inc. was incorporated in 1993 and is based in San Francisco, California. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1993
Employees 18
Stock Exchange OTCMKTS
Ticker Symbol ONPH
Full Company Profile

Financial Performance

In fiscal year 2013, Oncology Pharma's revenue was $10,214, a decrease of -92.42% compared to the previous year's $134,700. Earnings were $186,035, an increase of 216.79%.

Financial Statements

News

There is no news available yet.